Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer: results from the Trans-Tasman Radiation Oncology Group 96.01 randomised controlled trial
Top Cited Papers
- 1 November 2005
- journal article
- research article
- Published by Elsevier in The Lancet Oncology
- Vol. 6 (11) , 841-850
- https://doi.org/10.1016/s1470-2045(05)70348-x
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- 6-Month Androgen Suppression Plus Radiation Therapy vs Radiation Therapy Alone for Patients With Clinically Localized Prostate CancerJAMA, 2004
- Acceptability of short term neo-adjuvant androgen deprivation in patients with locally advanced prostate cancerRadiotherapy and Oncology, 2003
- Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostateInternational Journal of Radiation Oncology*Biology*Physics, 2001
- Predicting long-term survival, and the need for hormonal therapy: a meta-analysis of RTOG prostate cancer trialsInternational Journal of Radiation Oncology*Biology*Physics, 2000
- 4–Year Follow–Up Results of a European Prospective Randomized Study on Neoadjuvant Hormonal Therapy prior to Radical Prostatectomy in T2–3N0M0 Prostate CancerEuropean Urology, 2000
- NEOADJUVANT ANDROGEN ABLATION FOR LOCALIZED PROSTATIC CANCER: PATHOLOGY METHODS, SURGICAL END POINTS AND META-ANALYSIS OF RANDOMIZED TRIALSJournal of Urology, 1998
- Biochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate CancerJAMA, 1998
- Beneficial effect of combination hormonal therapy administered prior and following external beam radiation therapy in localized prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 1997
- Neoadjuvant Hormonal Deprivation before Radical ProstatectomyEuropean Urology, 1993
- Complete Androgen Deprivation prior to Radical Prostatectomy in Patients with Stage T(3) Cancer of the ProstateEuropean Urology, 1991